Trial intelligence / Profile preview

Estrogen Formulation and Route of Delivery on Skeletal Outcomes in FHA

NCT07010146Phase 2Recruiting

Sponsor
University of Virginia
Start
Oct 2025
Primary completion
Dec 2029
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol, ethinyl estradiol in Functional hypothalamic amenorrhea (FHA), sponsored by University of Virginia. Started Oct 2025; status: recruiting.

02

Drugs

estradiolethinyl estradiol
03

Conditions

Functional hypothalamic amenorrhea (FHA)

Beyond the preview

Go deeper on NCT07010146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07010146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call